Aurobindo Pharma

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE406A01037
NSEID: AUROPHARMA
BSEID: 524804
View on NSE | View on BSE

INR

1,508.50

11 (0.73%)

BSENSE

May 14

BSE+NSE Vol: 8.83 lacs

{
  "main_header": {
    "sid": 164981,
    "name": "Aurobindo Pharma",
    "stock_name": "Aurobindo Pharma",
    "full_name": "Aurobindo Pharma Ltd.",
    "name_url": "stocks-analysis/aurobindo-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,508.50",
    "chg": 11,
    "chgp": "0.73%",
    "dir": 1,
    "prev_price": "1,497.50",
    "mcapval": "87,613.92 Cr",
    "mcap": "Mid Cap",
    "scripcode": 524804,
    "symbol": "AUROPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE406A01037",
    "curr_date": "May 14",
    "curr_time": "",
    "bse_nse_vol": "8.83 lacs",
    "exc_status": "Active",
    "traded_date": "May 14, 2026",
    "traded_date_str": "2026 05 14",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aurobindo-pharma-164981-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1525",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-of-rs1525-on-14-may-2026-3990748",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AurobindoPharma_priceRelatedfactors_3990748.png",
        "date": "2026-05-14 09:40:09",
        "description": "With a decisive break above Rs 1525 on 14 May 2026, Aurobindo Pharma Ltd. has reached a fresh 52-week high, extending its impressive 24.87% return over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market indices."
      },
      {
        "title": "When is the next results date for Aurobindo Pharma Ltd.?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-aurobindo-pharma-ltd-3990097",
        "imagepath": "",
        "date": "2026-05-13 23:16:38",
        "description": "Aurobindo Pharma Ltd. will declare its results on 21 May 2026...."
      },
      {
        "title": "Aurobindo Pharma Ltd. is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aurobindo-pharma-ltd-is-rated-buy-by-marketsmojo-3985306",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AurobindoPharma_mojoScore_3985306.png",
        "date": "2026-05-11 10:11:13",
        "description": "Aurobindo Pharma Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Aurobindo Pharma Ltd: Valuation Shift Signals Price Attractiveness Change Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-valuation-shift-signals-price-attractiveness-change-amid-strong-returns-3984462",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AurobindoPharma_valuationdot_3984462.png",
        "date": "2026-05-11 08:00:11",
        "description": "Aurobindo Pharma Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its valuation metrics shift notably, moving from fair to expensive territory. Despite this, the stock has delivered robust returns well above the Sensex benchmark, prompting a reassessment of its price attractiveness relative to peers and historical averages."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1504",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-at-rs1504-3981449",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AurobindoPharma_priceRelatedfactors_3981449.png",
        "date": "2026-05-08 10:15:08",
        "description": "Surging to a fresh 52-week high of Rs 1504 on 8 May 2026, Aurobindo Pharma Ltd. has demonstrated robust price momentum, outpacing its sector and the broader market despite a subdued Sensex. This milestone caps a 29.81% rally from its 52-week low of Rs 1017, underscoring the stock’s sustained technical strength across multiple timeframes."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1497.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-at-rs149755-3979212",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AurobindoPharma_priceRelatedfactors_3979212.png",
        "date": "2026-05-07 09:40:05",
        "description": "With a decisive breakthrough to Rs 1497.55 on 7 May 2026, Aurobindo Pharma Ltd. has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum that outpaces the broader market’s modest gains."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1465",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-of-rs1465-on-6-may-2026-3977701",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AurobindoPharma_priceRelatedfactors_3977701.png",
        "date": "2026-05-06 10:35:05",
        "description": "Surging to a fresh 52-week high of Rs 1465 on 6 May 2026, Aurobindo Pharma Ltd. has demonstrated robust price momentum, outpacing its sector and the broader market with a 21.13% gain over the past year against the Sensex’s decline of 4.18%."
      },
      {
        "title": "Aurobindo Pharma Ltd. is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aurobindo-pharma-ltd-is-rated-buy-by-marketsmojo-3969952",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AurobindoPharma_mojoScore_3969952.png",
        "date": "2026-04-30 10:10:38",
        "description": "Aurobindo Pharma Ltd. is rated Buy by MarketsMOJO, with this rating last updated on 24 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Aurobindo Pharma Gains 2.03%: 6 Key Factors Driving the Weekly Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-gains-203-6-key-factors-driving-the-weekly-rally-3963313",
        "imagepath": "",
        "date": "2026-04-26 14:01:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Apr:</strong> New 52-week high at Rs.1,396.6</p>\n                    <p><strong>21 Apr:</strong> All-time high reached at Rs.1,401</p>\n                    <p><strong>22 Apr:</strong> New 52-week high of Rs.1,415</p>\n                    <p><strong>23 Apr:</strong> New 52-week high at Rs.1,429.8</p>\n                    <p><strong>24 Apr:</strong> Week closes at Rs.1,413.8 (-1.54% on day)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,367.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat..."
      }
    ],
    "total": 793,
    "sid": "164981",
    "stock_news_url": "https://www.marketsmojo.com/news/aurobindo-pharma-164981"
  },
  "announcements": [
    {
      "details": "Aurobindo Pharma Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Aurobindo Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "28-Nov-2019"
    },
    {
      "details": "Aurobindo Pharma Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "Aurobindo Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "15-Nov-2019"
    },
    {
      "details": "Aurobindo Pharma Limited has informed the Exchange regarding 'Completion of USFDA Inspection at our Unit IV Reg.,'.",
      "source": "NSE",
      "caption": "Aurobindo Pharma Limited - Updates",
      "datetime": "14-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "21 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:5</strong> stock split, ex-date: 10 Feb 11",
          "dt": "2011-02-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aurobindo Pharma Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 20 Jul 15",
          "dt": "2015-07-20",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1525

2026-05-14 09:40:09

With a decisive break above Rs 1525 on 14 May 2026, Aurobindo Pharma Ltd. has reached a fresh 52-week high, extending its impressive 24.87% return over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained outperformance relative to the broader market indices.

Read full news article

When is the next results date for Aurobindo Pharma Ltd.?

2026-05-13 23:16:38

Aurobindo Pharma Ltd. will declare its results on 21 May 2026....

Read full news article

Aurobindo Pharma Ltd. is Rated Buy by MarketsMOJO

2026-05-11 10:11:13

Aurobindo Pharma Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 May 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Aurobindo Pharma Ltd: Valuation Shift Signals Price Attractiveness Change Amid Strong Returns

2026-05-11 08:00:11

Aurobindo Pharma Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its valuation metrics shift notably, moving from fair to expensive territory. Despite this, the stock has delivered robust returns well above the Sensex benchmark, prompting a reassessment of its price attractiveness relative to peers and historical averages.

Read full news article

Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1504

2026-05-08 10:15:08

Surging to a fresh 52-week high of Rs 1504 on 8 May 2026, Aurobindo Pharma Ltd. has demonstrated robust price momentum, outpacing its sector and the broader market despite a subdued Sensex. This milestone caps a 29.81% rally from its 52-week low of Rs 1017, underscoring the stock’s sustained technical strength across multiple timeframes.

Read full news article

Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1497.55

2026-05-07 09:40:05

With a decisive breakthrough to Rs 1497.55 on 7 May 2026, Aurobindo Pharma Ltd. has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum that outpaces the broader market’s modest gains.

Read full news article

Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1465

2026-05-06 10:35:05

Surging to a fresh 52-week high of Rs 1465 on 6 May 2026, Aurobindo Pharma Ltd. has demonstrated robust price momentum, outpacing its sector and the broader market with a 21.13% gain over the past year against the Sensex’s decline of 4.18%.

Read full news article

Aurobindo Pharma Ltd. is Rated Buy by MarketsMOJO

2026-04-30 10:10:38

Aurobindo Pharma Ltd. is rated Buy by MarketsMOJO, with this rating last updated on 24 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.